The black market for breastmilk isn’t exactly so secret anymore. Back in 2025, a TikToker boasted that she made over $13,000 by selling their breastmilk to bodybuilders, convinced that it would help ...
NEWARK, DELAWARE / ACCESS Newswire / February 9, 2026 / The global colostrum market is entering a decisive growth phase, driven by expanding applications in sports nutrition, immunity support, infant ...
Generic Protocols for Analytical Validation of Tumor-Informed Circulating Tumor DNA Assays for Molecular Residual Disease: The Blood Profiling Atlas in Cancer's Molecular Residual Disease Analytical ...
The tibremciclib trial demonstrated a significant PFS benefit and high objective response rates in a single-country cohort without prior CDK4/6 inhibitor exposure. Overall survival (OS) data remain ...
Colostrum isn’t some vague “immune booster” – it’s a biologically active compound engineered by nature to repair, rebuild, and regulate. For women, that may mean more than just cold-season immunity: ...
Forbes contributors publish independent expert analyses and insights. David Henkin helps organizations and individuals innovate and grow. It might be tempting to believe that growth is purely a matter ...
Since first adopting Toast as a brand-wide Point-of-Sale system, The Human Bean has grown from under 70 locations to nearly 200 stores, with many more in development. The rapid expansion of the coffee ...
The regulatory greenlight was backed by two Phase III trials that showed normalized growth hormone levels in patients with the rare pituitary condition. It’s the first approval for Crinetics ...
Sleep is often treated as downtime, a passive break between the real business of being awake. But a new study has revealed that sleep is active, essential biology, showing how the brain uses the night ...
The addition of the hormone progesterone to gender-affirming hormone therapy leads to increased breast growth for transgender people following feminising hormone therapy. This is demonstrated by an ...
The FDA has approved the once-weekly injectable lonapegsomatropin-tcgd (Skytrofa, Ascendis Pharma A/S) for replacing endogenous growth hormone in adults with growth hormone deficiency (GHD), expanding ...